Aqemia is a pharmaceutical technology company focused on drug invention. Its stated mission is the creation of entirely new medicines to address major unmet medical needs in healthcare. The company operates at the intersection of fundamental science and computational methods.
Central to Aqemia's approach is its proprietary platform, QEMI. This molecule-invention system is designed to generate novel drug candidates by modelling molecular interactions from first principles. The underlying technology draws on several distinct technical disciplines:
- Physics-based modeling
- Statistical mechanics
- Generative AI
As a drug invention company, Aqemia's work sits within the pharmaceutical vertical. The firm positions itself as dedicated to advancing the preclinical stages of drug discovery through its computational approach.
